To determine whether the prevalence of resistance to commonly used oral antimicrobial agents varied over time, we compared the in vitro susceptibilities of 217 strains of Haemophilus influenzae recovered from nasopharyngeal secretions of children in a day-care Oenter studied longitudinally between 1979 and 1987. The overall rate of 13-lactamase production in these strains was 18%, with rates of 57% in type b isolates (n = 21) and 14% in non-type b isolates (n = 196). The percentages of isolates for which MICs were '1.0 ,ug/ml for amoxicillin alone, amoxicillin in combination with clavulanic acid, and cefuroxime alone were 82, 92, and 93%, respectively. The percentage of strains for which cefaclor MICs were s1.0 ,ug/ml was only 0.5%. Isolates for which chloramphenicol MICs were >2.0 ,ug/ml or for which trimethoprim-sulfamethoxazole MICs were >0.5/9.5 pg/ml were uncommon: 1 and <1%, respectively. High concentrations of erythromycin alone and in combination with sulfisoxazole were required to inhibit the majority of test strains; there was no evidence of erythromycin-sulfisoxazole synergy. In vitro susceptibility to commonlly used oral antimicrobial agents remained at a constant level when H. influenzae isolates collected from children in a day'catae center during 1979 through 1983 were compared with strains collected during 1984 through 1987.
Haemophilus influenzae is an important bacterial pathogen of the upper respiratory tract during childhood (2). Nonencapsulated (nontypeable) strains are common causes of conjunctivitis, otitis media, and maxillary sinusitis (9, 16, 36) . Although these localized mucosal infections are rarely life-threatening, they are associated with significant morbidity; otitis media alone accounts for up to 40% of all pediatric office visits (17, 34) .
The prevalence of otitis media appears to be two to four times higher in children attending group day-care,centers than it is in children cared for at home or in smaller day-care environments in homes (22, 27, 32, 35) . The clinical diagnosis of middle ear infection in children in group day-care centers typically results in empiric therapy with orally administered antimicrobial agents. The frequent use of these antimicrobial agents could contribute to the emergence of antibiotic-resistant pathogens within pediatric populations (13, 31) . We recently reported a high rate of nasopharyngeal carriage of antibiotic-resistant pneumococci by children in a day-care center environment (14) . In that report, we documented an increasing rate of pneumococcal resistance to trimethoprim-sulfamethoxazole during the 5 years of its use in that setting. Because colonizing H. influenzae strains were exposed to the same antibiotic pressures as the previously studied pneumococci, we were concerned that similar resistance trends could be occurring in H. influenzae carried by children in this day-care center population. The present investigation was undertaken to determine, in a longitudinal fashion, the prevalence of resistance to commonly used antimicrobial agents in H. influenzae strains carried by these attendees of a day-care center.
(This work was presented in part at the 89th Annual Meeting of the American Society for Microbiology, New Orleans, La., 14 to 18 May 1989 [8a] .) MATERIALS AND METHODS bay-care stidy population. The isolates of H. influenzae studied were recovered from nasopharyngeal secretions of children attel'ng the Frank Porter Graham Child Development Center. Details of the recruiiment of these children and of the longitudinal design of respiratory infection surveillance conducted in this population have been published in previous reports (11, 12) . Briefly, a cohort of 10 to 12 infants 2 to 3 months of age was admitted to the day-care program each year. Children attended the center for 8 h a day, 5 days a week, 50 weeks a year. Approximately 80% of the children ehrolled were followed continuously in this setting from etrly infancy to entrance into kindergarten.
Recovery of isolates. Bacterial surveillance cultures of upper respiratory tract secretions were performed each month. In addition, samples of upper respiratory tract secretions were cultured for viruses and bacteria at the onset of each respiratory illness. Respiratory secretions were obtained by performing a saline nasal wash. Aliquots of the wash fluid were streaked onto sheep blood and chocolate agar which idi turn were incubated at 37°C in 5% CO2.
Isolates of H. influenzae were identified by characteristic colony morphology, Gram stain morphology, and hemin and NAD requirement by using X-, V-, and XV-factor paper strips (BBL, Cockeysville, Md.) (19) . In addition, all of the isolates were examined for capsular antigens by a slide agglutination procedure by using the Bacto H. influenzae antisera set (Difco Laboratories, Detroit, Mich.).
The test strains used in this study were isolated during the The ability of H. influenzae isolates to produce P-lactamase was determined by using the chromogenic cephalosporin nitrocefin. Table 1 summarizes the prevalence of ,-lactamase production and the distribution of that production by isolate serotype. One hundred four of the strains tested were recovered during 1979 through 1983. Nineteen (18%) of these strains were positive for ,-lactamase production. Seventythree percent of the 15 type b strains recovered in this time period produced 1-lactamase. None of the type e or f strains and 9% of the 87 nontypeable strains were ,-lactamase positive. One hundred thirteen strains were recovered during the 1984 through 1987 time period, and 20 or, again, 18% of those isolates were positive for ,-lactamase production. Seventeen percent of the 6 type b strains, 10% of the type e strains, 0% of the type f strains, and 21% of the 85 nontypeable strains were positive for ,-lactamase production in the later time period. The in vitro susceptibility of H. influenzae to four betalactam agents is shown in Table 2 . The MICs of amoxicillin for 50% (MlC50) and 90% (MIC90) of the P-lactamasepositive strains tested were >16.0 jig/ml. Amoxicillin MICs for all strains lacking 13-lactamase activity were .1.0 ,ug/ml.
All strains for which amoxicillin MICs were >1.0 ;ig/ml were f-lactamase positive.
Clavulanic acid was effective in vitro in inhibiting f3-lactamase activity, as indicated by the reduction of amoxicillin MICs when a 2:1 combination of amoxicillin and clavulanic acid was used to test ,-lactamase-positive strains.
Cefuroxime was found to be more active against the H.
influenzae isolates tested than was cefaclor, with MIC90s of 1.0 and 16.0 ,ug/ml, respectively. The cefaclor MIC was .1.0 ,ug/ml for only one test isolate, while for more than 90% of the test isolates, cefuroxime MICs were <1.0 ,ug/ml. As indicated in Table 2 , H. influenzae susceptibility to cephalosporins was not significantly influenced by P-lactamase production. The MICs of other antimicrobial agents for H. influenzae are presented in Table 3 . Chloramphenicol MICs were 4.0 ,ug/ml for three isolates (1%), while chloramphenicol MICs ranged from 0.06 to 1.0 ,ug/ml for the remaining strains. The three strains with reduced susceptibility to chloramphenicol were recovered from two of the children in the study, were serologically nontypeable, and were P-lactamase positive.
Trimethoprim-sulfamethoxazole MICs ranged from c0.03/ 0.59 to 1.00/19.0 jxg/ml, with a median MIC of 0.125/2.38
;ig/ml. Trimethoprim-sulfamethoxazole MICs for only 2 (<1%) of the 217 isolates studied were >0.5/9.5 jig/ml. The two strains for which the MICs were increased were recovered from different children, were serotype b, were 1-lactamase positive, and were susceptible to chloramphenicol. Trimethoprim MICs were c0.5 ,ug/ml for 65% of the H. influenzae strains when they were tested against this antimicrobial agent alone. None of the isolates was inhibited by sulfamethoxazole alone at concentrations of .9.5 ,ug/ml. Antimicrobial synergy was displayed against 54% of the H. influenzae strains tested; MICs of the two drugs in combination were greater than or equal to fourfold lower than the MICs of trimethoprim and sulfamethoxazole when they were tested separately against these isolates. Erythromycin-sulfisoxazole MICs were .0.5/32 ,ug/ml for only 5% of the isolates studied. High concentrations of erythromycin and sulfisoxazole alone were required to inhibit the majority of strains tested. Erythromycin MICs were s0.5 ,ug/ml for only 2% of the isolates studied, while sulfisoxazole MICs were .32 ,ug/ml for 3% of the isolates studied when they were tested against each of these two drugs alone. Although the combination of erythromycinsulfisoxazole was more active than erythromycin alone, the combination had activity essentially equal to that of sulfisoxazole alone, with synergy demonstrated in only 0.5% of the isolates tested.
Comparison of MIC50 and MIC90 data for 1979 through 1983 and 1984 through 1987 indicated no significant differences in susceptibilities to the antimicrobial agents during the two time periods studied. In addition, the proportion of isolates susceptible to concentrations of antimicrobial agents usually achieved in middle ear fluid remained consistent over the period of study (Table 4) .
DISCUSSION
Recent reports have suggested that day-care center attendance and trends in antibiotic use in children attending day-care centers can influence the epidemiology of antimicrobial resistance in pediatric bacterial pathogens (13, 31) . We previously conducted an antibiotic resistance survey for pneumococci in a day-care population and found periods of time when the prevalence of pneumococci with reduced susceptibilities to both penicillin G and trimethoprim-sulfamethoxazole was relatively high (14) . We undertook the present investigation to survey the extent of antibiotic resistance in strains of H. influenzae colonizing the upper respiratory tracts of children attending the same day-care center. Because otitis media was the most common illness requiring antibiotic treatment in this group of children, susceptibility results from this study were based on the concentrations of antimicrobial agents achievable in middle ear fluid.
The overall rate of ,B-lactamase production for all the isolates investigated in this study was 18%. P-Lactamase production was documented in 57% of all the type b isolates and 14% of the total non-type b isolates tested: On the basis of a comparison of the ,B-lactamase positivity of total isolates from the first 5 years of our study with that of the last 4 years, the prevalence of P-lactamase-producing H. influenzae strains did not increase in our day-care population.
The serotype distribution of P-lactamase production did appear to change; however, the number of organisms tested was too small to determine the significance of this observation.
,B-Lactamase activity was inhibited, and reductions in the amoxicillin MICs were demonstrated when 1-lactamasepositive isolates were tested for their susceptibility to amoxicillin in combination with the ,-lactamase inhibitor clavulanic acid. However, for only 56% of these isolates tested against this combination were amoxicillin MICs reduced to the levels seen for P-lactamase negative strains or to levels readily achieved in middle ear fluid (.1.0 ,ug/ml) (10, 15, 21, 26) .
There was no apparent trend of increasing resistance to cefaclor or cefuroxime among the isolates examined in the present investigation. Of interest, however, was that cefuroxime MICs were .l1.0 jxg/ml for 201 (93%) of the 217 H. influenzae strains tested, while cefaclor MICs were .1.0 ,ug/ml for less than 1% of the isolates; .1.0 jig/ml is the concentration of these cephalosporin agents usually attained in middle ear fluid (7, 21, 23, 24, 26) . Our findings regarding cefaclor are compatible with those of other investigators. In a 1978 study of clinical H. influenzae isolates, fewer than 10% of the strains were inhibited by a concentration of 0.78 ,g of cefaclor per ml (29) . In a more recent national survey of 2,811 clinical isolates, only 5% were inhibited by cefaclor at a concentration of .1.0 jig/ml (6) . In contrast to cefaclor, the cefuroxime MIC90 for 100 clinical isolates in a 1983 study was 1.0 j,g/ml (8) .
H. influenzae strains for which chloramphenicol MICs were >2.0 ,ug/ml were uncommon (1%) in the strains from the day-care population that we studied, as they have been in recent national surveys (5, 6) . Since 1972, chloramphenicol resistance has been reported in both type b and non-type b H. influenzae clinical isolates. A large proportion of these clinical strains also have been resistant to ampicillin, tetracycline, and trimethoprim-sulfamethoxazole (3, 25) . All three of our strains for which chloramphenicol MICs were increased were non-type b and I-lactamase positive, but they were trimethoprim-sulfamethoxazole susceptible. Tetracycline was not tested against our study isolates.
The antimicrobial combination trimethoprim-sulfamethoxazole was highly active in vitro against our H. influenzae study strains at concentrations achievable in middle ear fluid, .0.5/9.5 jig/ml (20, 21) . Antibiotic synergy was demonstrated against 54% of the study isolates tested against this combination. In studies by other investigators, -99% of both clinical isolates and survey isolates from healthy children were susceptible to .0.5/9.5 ug of trimethoprim-sulfamethoxazole per ml (4, 6, 29) . The opposite was true in our previous experience with pneumococci (14) ; the use of trimethoprim-sulfamethoxazole resulted in the rapid selection of strains with reduced susceptibilities to this drug combination. Before the introduction of trimethoprim-sulfamethoxazole in 1981, pneumococcal resistance to this drug was only 5% in the day-care study population. Resistance rose to 39%, however, during the 5 years following the introduction of this antimicrobial agent. Of interest is the fact that the H. influenzae isolates we tested in the present study had experienced the same antibiotic pressures as the previously tested pneumococcal isolates, yet there was no increase in the prevalence of resistance to trimethoprimsulfamethoxazole in the H. influenzae isolates examined in this study.
High concentrations of both erythromycin and sulfisoxazole alone and in combination were required to inhibit the majority of H. influenzae strains studied in the present investigation. On the basis of the current literature, probably no more than 0.5 ,ug of erythromycin per ml is achievable in the middle ear when it is given in the form of erythromycin ethylsuccinate (1, 10, 26, 33) ; 98% of the isolates we tested were not susceptible to this concentration of erythromycin in vitro. In a recent national survey, comparable results were observed, in which erythromycin MICs were s0.5 ,ug/ml for only 1% of the strains tested (6) .
Erythromycin ethylsuccinate-sulfisoxazole is a commonly prescribed combination therapy for otitis media (1, 10, 26, 33) . However, in this investigation we found a very high prevalence (95%) of H. influenzae strains that were not susceptible to this combination in vitro when s0.5/32.0 ,ug of erythromycin-sulfisoxazole per ml was used as the criterion for susceptibility. In another study that tested the same ratio of these two drugs, only 37% of the H. influenzae isolates were inhibited by O0.5/32 ,ug of the combination per ml (32) .
Also, in our investigation we found little evidence that the combination of erythromycin and sulfisoxazole (1:64) is synergistic against those isolates tested.
In this investigation, we studied in a longitudinal fashion the in vitro antimicrobial susceptibility of H. influenzae isolates recovered from nasopharyngeal secretions of children known to have high rates of exposure to antibiotics secondary to increased rates of otitis media. The survey was undertaken to determine the prevalence of resistance to antimicrobial agents commonly used for the treatment of middle ear infections. In particular, we were interested in trends in resistance to trimethoprim-sulfamethoxazole because increases in resistance to this antimicrobial agent were previously documented in pneumococci carried by children in this same population. In summary, many of the H. influenzae isolates tested were not susceptible to the antimicrobial concentrations achievable in middle ear fluid; however, there was no observable trend toward resistance to trimethoprim-sulfamethoxazole or to any of the other oral antimicrobial agents studied in this investigation.
